{"id":"W2925250388","doi":"10.1111/bjd.17918","title":"Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Merck","keywords":"Medicine; Pharmacokinetics; Immunogenicity; Monoclonal; Interleukin 23; Monoclonal antibody; Clinical trial; Internal medicine; Pharmacology; Antibody; Interleukin 17; Immunology; Cytokine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00267798,0.0002854649,0.0004111308,0.00009354809,0.0001248277,0.0003632722,0.0001524877,0.0002164481,0.0009927294],"category_scores_gemma":[0.002185834,0.0001351741,0.0004424655,0.0000846773,0.0001957126,0.0003110032,0.0001329374,0.000674304,0.0001848112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002972055,"about_ca_system_score_gemma":0.0002233816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001054384,"about_ca_topic_score_gemma":0.0001367429,"domain_scores_codex":[0.9990559,0.0005326811,0.00007958826,0.00008866891,0.0001643494,0.00007885835],"domain_scores_gemma":[0.9982173,0.0007987789,0.0005484297,0.000131874,0.0001278723,0.0001756962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1864612,0.009319361,0.2072444,0.0006603916,0.001631625,0.0004108372,0.0003263089,0.004101343,0.2748666,0.0003631986,0.0007929262,0.3138219],"study_design_scores_gemma":[0.01619098,0.4126082,0.4209745,0.00008137882,0.0015156,0.002410428,0.0001036516,0.006860317,0.1331813,0.0002946147,0.005737599,0.00004151036],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980414,0.001083223,0.0002910345,0.00005091704,0.000008973688,0.00004927101,0.00003758833,0.000007258858,0.0004303412],"genre_scores_gemma":[0.9995613,0.0001130615,0.0001377354,0.00002509903,0.0000158639,0.00002002412,0.00003788222,0.000001690601,0.00008735004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00267798,"threshold_uncertainty_score":0.01416266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00609147270162685,"score_gpt":0.2360848474658084,"score_spread":0.2299933747641816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}